Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This means you spend less time sore and more time training hard
The other is because you were seeing adverse events. Neither is good news for BPC-157
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Small-molecule NNMT inhibitor often discussed with metabolic protocols
The shorter working life of a 50mg vial is part of what makes it the safer choice for sensitive work, so there is little value in extending that window unnecessarily
Systemic Injection One of BPC-157s interesting properties is its ability to migrate toward areas of tissue damage regardless of injection site
Chemical Engineering Journal, 492, 152154
